Laura Marín

752 total citations
22 papers, 562 citations indexed

About

Laura Marín is a scholar working on Genetics, Epidemiology and Economics and Econometrics. According to data from OpenAlex, Laura Marín has authored 22 papers receiving a total of 562 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Genetics, 8 papers in Epidemiology and 5 papers in Economics and Econometrics. Recurrent topics in Laura Marín's work include Inflammatory Bowel Disease (14 papers), Microscopic Colitis (8 papers) and Health Systems, Economic Evaluations, Quality of Life (5 papers). Laura Marín is often cited by papers focused on Inflammatory Bowel Disease (14 papers), Microscopic Colitis (8 papers) and Health Systems, Economic Evaluations, Quality of Life (5 papers). Laura Marín collaborates with scholars based in Spain, Australia and Italy. Laura Marín's co-authors include Eugeni Domènech, Míriam Mañosa, Eduard Cabré, Yamile Zabana, Esther García-Planella, Jordi Gordillo, Margalida Calafat, Isabel Bernal, Miquel A. Gassull and Triana Lobatón and has published in prestigious journals such as Gastroenterology, European Journal of Pharmaceutics and Biopharmaceutics and Digestive Diseases and Sciences.

In The Last Decade

Laura Marín

22 papers receiving 558 citations

Peers

Laura Marín
Comparison fields: 5 of 71
  • Genetics 316
  • Epidemiology 212
  • Surgery 171
  • Public Health, Environmental and Occupational Health 145
  • Immunology 117
G. A. Moody United Kingdom
Esther García-Planella Spain
David N. Moskovitz Canada
Anna Pupco Canada
Ingrid Prytz Berset Norway
Paulo Gustavo Kotze Brazil
Ewa Toporowska‐Kowalska Poland
Idit Segal Israel
Bobby Lo Denmark
Beth Kaplan United States
G. A. Moody United Kingdom View profile →
Citations per field, relative to Laura Marín
Laura Marín · 1×
Citations per year, relative to Laura Marín
Laura Marín · 1×

Countries citing papers authored by Laura Marín

Since Specialization
Citations

This map shows the geographic impact of Laura Marín's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Marín with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Marín more than expected).

Fields of papers citing papers by Laura Marín

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Marín. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Marín. The network helps show where Laura Marín may publish in the future.

Co-authorship network of co-authors of Laura Marín

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Marín. A scholar is included among the top collaborators of Laura Marín based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Marín. Laura Marín is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Title Journal Authors Indexed citations
1 Determinación de la contribución de valor de filgotinib para el tratamiento de la colitis ulcerosa de moderada a grave mediante el análisis de decisión multicriterio (MCDA) Carlos Taxonera, Laura Marín et al. 1
2 Treatment Adherence and Clinical Outcomes of Patients with Inflammatory Bowel Disease on Biological Agents During the SARS-CoV-2 Pandemic Digestive Diseases and Sciences Laura Marín, Margalida Calafat et al. 8
3 Patient-Evaluated Quality of Care is Related to Better Inflammatory Bowel Disease Outcomes: The IQCARO II Project Patient Xavier Calvet, Francesc Casellas et al. 2
4 COVID-19 y enfermedad inflamatoria intestinal: preguntas surgidas de la atención y seguimiento de los pacientes durante la fase inicial de la pandemia (febrero-abril 2020) Gastroenterología y Hepatología Ignacio Marín‐Jiménez, Yamile Zabana et al. 12
5 Association between Salivary Alpha-Amylase and Executive Functioning in Healthy Children The Spanish Journal of Psychology E. Maldonado, Laura Marín et al. 6
6 Development and validation of the QUECOMIICAT questionnaire: a tool to assess disease-related knowledge in patients with inflammatory bowel disease Revista Española de Enfermedades Digestivas Francesc Casellas, Laura Marín et al. 7
7 Impact of pain associated with the subcutaneous administration of adalimumab Gastroenterología y Hepatología Laura Marín, Jordi Gordillo et al. 19
8 Improving Quality of Care in Inflammatory Bowel Disease Through Patients’ Eyes: IQCARO Project Inflammatory Bowel Diseases Xavier Calvet, Daniel Carpio et al. 12
9 Therapeutic requirements in active ulcerative proctitis: A single-centre study Gastroenterología y Hepatología Margalida Calafat, Triana Lobatón et al. 4
10 Fecal Calprotectin Levels Are Closely Correlated with the Absence of Relevant Mucosal Lesions in Postoperative Crohnʼs Disease Inflammatory Bowel Diseases Esther García-Planella, Míriam Mañosa et al. 30
11 High Within-day Variability of Fecal Calprotectin Levels in Patients with Active Ulcerative Colitis Inflammatory Bowel Diseases Margalida Calafat, Eduard Cabré et al. 82
12 Addition of mesalazine for subclinical post‐surgical endoscopic recurrence of Crohn's disease despite preventive thiopurine therapy: A case–control study Journal of Gastroenterology and Hepatology Yamile Zabana, Míriam Mañosa et al. 6
13 Multiple dosing of simvastatin inhibits airway mucus production of epithelial cells: Implications in the treatment of chronic obstructive airway pathologies European Journal of Pharmaceutics and Biopharmaceutics Laura Marín, Daniela Traini et al. 24
14 Fecundity, pregnancy outcomes, and breastfeeding in patients with inflammatory bowel disease: a large cohort survey Scandinavian Journal of Gastroenterology Míriam Mañosa, Mercè Navarro‐Llavat et al. 69
15 Development of quality standards in inflammatory bowel disease management and design of an evaluation tool of nursing care Revista Española de Enfermedades Digestivas Antonio Torrejón, Laura Marín et al. 9
16 Sexual function and patients' perceptions in inflammatory bowel disease: a case–control survey Journal of Gastroenterology Laura Marín, Míriam Mañosa et al. 95
17 Nursing resources and responsibilities according to hospital organizational model for management of inflammatory bowel disease in Spain Journal of Crohn s and Colitis Laura Marín, Antonio Torrejón et al. 9
18 Contribution of nurses to the quality of care in management of inflammatory bowel disease: A synthesis of the evidence Journal of Crohn s and Colitis Laura Marín, Antonio Torrejón et al. 47
19 Utilización de medicinas alternativas y consumo de drogas por pacientes con enfermedad inflamatoria intestinal Medicina Clínica Esther García-Planella, Laura Marín et al. 21
20 Medication-Taking Behavior in a Cohort of Patients with Inflammatory Bowel Disease Digestive Diseases and Sciences Isabel Bernal, Eugeni Domènech et al. 96

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026